
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Selective Reversible Inhibition of Liver Carnitine Palmitoyl-Transferase 1 by Teglicar Reduces Gluconeogenesis and Improves Glucose Homeostasis
Roberto Conti, Edoardo Mannucci, Pompeo Pessotto, et al.
Diabetes (2011) Vol. 60, Iss. 2, pp. 644-651
Open Access | Times Cited: 83
Roberto Conti, Edoardo Mannucci, Pompeo Pessotto, et al.
Diabetes (2011) Vol. 60, Iss. 2, pp. 644-651
Open Access | Times Cited: 83
Showing 1-25 of 83 citing articles:
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Steven E. Kahn, Mark E. Cooper, Stefano Del Prato
The Lancet (2013) Vol. 383, Iss. 9922, pp. 1068-1083
Open Access | Times Cited: 1543
Steven E. Kahn, Mark E. Cooper, Stefano Del Prato
The Lancet (2013) Vol. 383, Iss. 9922, pp. 1068-1083
Open Access | Times Cited: 1543
The interaction of hepatic lipid and glucose metabolism in liver diseases
Lars P. Bechmann, Rebekka A. Hannivoort, Guido Gerken, et al.
Journal of Hepatology (2011) Vol. 56, Iss. 4, pp. 952-964
Open Access | Times Cited: 871
Lars P. Bechmann, Rebekka A. Hannivoort, Guido Gerken, et al.
Journal of Hepatology (2011) Vol. 56, Iss. 4, pp. 952-964
Open Access | Times Cited: 871
CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential
Isabel R. Schlaepfer, Molishree Joshi
Endocrinology (2020) Vol. 161, Iss. 2
Open Access | Times Cited: 474
Isabel R. Schlaepfer, Molishree Joshi
Endocrinology (2020) Vol. 161, Iss. 2
Open Access | Times Cited: 474
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
Qian Qu, Fanning Zeng, Xiaonan Liu, et al.
Cell Death and Disease (2016) Vol. 7, Iss. 5, pp. e2226-e2226
Open Access | Times Cited: 459
Qian Qu, Fanning Zeng, Xiaonan Liu, et al.
Cell Death and Disease (2016) Vol. 7, Iss. 5, pp. e2226-e2226
Open Access | Times Cited: 459
CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis
Ying-Nan Wang, Zhao-Lei Zeng, Jiahuan Lu, et al.
Oncogene (2018) Vol. 37, Iss. 46, pp. 6025-6040
Closed Access | Times Cited: 297
Ying-Nan Wang, Zhao-Lei Zeng, Jiahuan Lu, et al.
Oncogene (2018) Vol. 37, Iss. 46, pp. 6025-6040
Closed Access | Times Cited: 297
Mitochondrial Fatty Acid Oxidation in Obesity
Dolors Serra, Paula Mera, Maria Ida Malandrino, et al.
Antioxidants and Redox Signaling (2012) Vol. 19, Iss. 3, pp. 269-284
Open Access | Times Cited: 215
Dolors Serra, Paula Mera, Maria Ida Malandrino, et al.
Antioxidants and Redox Signaling (2012) Vol. 19, Iss. 3, pp. 269-284
Open Access | Times Cited: 215
Triglyceride cycling enables modification of stored fatty acids
Klaus Wunderling, Jelena Zurkovic, Fabian Zink, et al.
Nature Metabolism (2023) Vol. 5, Iss. 4, pp. 699-709
Open Access | Times Cited: 52
Klaus Wunderling, Jelena Zurkovic, Fabian Zink, et al.
Nature Metabolism (2023) Vol. 5, Iss. 4, pp. 699-709
Open Access | Times Cited: 52
Mitochondrial CPT1A: Insights into structure, function, and basis for drug development
Kai Liang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 47
Kai Liang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 47
Nonalcoholic Fatty Liver Disease: Pathogenesis and Therapeutics from a Mitochondria-Centric Perspective
Aaron M. Gusdon, Kexiu Song, Shen Qu
Oxidative Medicine and Cellular Longevity (2014) Vol. 2014, pp. 1-20
Open Access | Times Cited: 153
Aaron M. Gusdon, Kexiu Song, Shen Qu
Oxidative Medicine and Cellular Longevity (2014) Vol. 2014, pp. 1-20
Open Access | Times Cited: 153
Dissociating fatty liver and diabetes
Zheng Sun, Mitchell A. Lazar
Trends in Endocrinology and Metabolism (2012) Vol. 24, Iss. 1, pp. 4-12
Open Access | Times Cited: 132
Zheng Sun, Mitchell A. Lazar
Trends in Endocrinology and Metabolism (2012) Vol. 24, Iss. 1, pp. 4-12
Open Access | Times Cited: 132
Impaired mitochondrial fat oxidation induces adaptive remodeling of muscle metabolism
Shawna Wicks, Bolormaa Vandanmagsar, Kimberly R. Haynie, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 25
Open Access | Times Cited: 117
Shawna Wicks, Bolormaa Vandanmagsar, Kimberly R. Haynie, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 25
Open Access | Times Cited: 117
Carnitine Inborn Errors of Metabolism
Mohammed Almannai, Majid Alfadhel, Ayman W. El‐Hattab
Molecules (2019) Vol. 24, Iss. 18, pp. 3251-3251
Open Access | Times Cited: 100
Mohammed Almannai, Majid Alfadhel, Ayman W. El‐Hattab
Molecules (2019) Vol. 24, Iss. 18, pp. 3251-3251
Open Access | Times Cited: 100
Altered mitochondrial metabolism in the insulin‐resistant heart
Marina Makrecka-Kūka, E. Liepinsh, Andrew J. Murray, et al.
Acta Physiologica (2019) Vol. 228, Iss. 3
Open Access | Times Cited: 76
Marina Makrecka-Kūka, E. Liepinsh, Andrew J. Murray, et al.
Acta Physiologica (2019) Vol. 228, Iss. 3
Open Access | Times Cited: 76
Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism
Luke Norton, Marcel Fourcaudot, Muhammad Abdul-Ghani, et al.
Diabetologia (2011) Vol. 54, Iss. 12, pp. 3132-3142
Open Access | Times Cited: 87
Luke Norton, Marcel Fourcaudot, Muhammad Abdul-Ghani, et al.
Diabetologia (2011) Vol. 54, Iss. 12, pp. 3132-3142
Open Access | Times Cited: 87
The Metabolic Landscape of Prostate Cancer
Francesca Giunchi, Michelangelo Fiorentino, Massimo Loda
European Urology Oncology (2018) Vol. 2, Iss. 1, pp. 28-36
Closed Access | Times Cited: 81
Francesca Giunchi, Michelangelo Fiorentino, Massimo Loda
European Urology Oncology (2018) Vol. 2, Iss. 1, pp. 28-36
Closed Access | Times Cited: 81
Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems
Alejandro Soto–Gutiérrez, Albert Gough, Lawrence A. Vernetti, et al.
Experimental Biology and Medicine (2017) Vol. 242, Iss. 16, pp. 1605-1616
Open Access | Times Cited: 75
Alejandro Soto–Gutiérrez, Albert Gough, Lawrence A. Vernetti, et al.
Experimental Biology and Medicine (2017) Vol. 242, Iss. 16, pp. 1605-1616
Open Access | Times Cited: 75
MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma
Ganna Oliynyk, María Victoria Ruiz-Pérez, Lourdes Sainero‐Alcolado, et al.
iScience (2019) Vol. 21, pp. 188-204
Open Access | Times Cited: 63
Ganna Oliynyk, María Victoria Ruiz-Pérez, Lourdes Sainero‐Alcolado, et al.
iScience (2019) Vol. 21, pp. 188-204
Open Access | Times Cited: 63
The role and therapeutic implication of CPTs in fatty acid oxidation and cancers progression
Junmin Wang, Hongjiao Xiang, Yifei Lü, et al.
American Journal of Cancer Research (2021) Vol. 11, Iss. 6, pp. 2477-2494
Closed Access | Times Cited: 42
Junmin Wang, Hongjiao Xiang, Yifei Lü, et al.
American Journal of Cancer Research (2021) Vol. 11, Iss. 6, pp. 2477-2494
Closed Access | Times Cited: 42
Endogenous renal adiponectin drives gluconeogenesis through enhancing pyruvate and fatty acid utilization
Toshiharu Onodera, May-Yun Wang, Joseph M. Rutkowski, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Toshiharu Onodera, May-Yun Wang, Joseph M. Rutkowski, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
The Physiological and Pathological Role of Acyl-CoA Oxidation
Sylwia Szrok-Jurga, Aleksandra Czumaj, Jacek Turyn, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14857-14857
Open Access | Times Cited: 16
Sylwia Szrok-Jurga, Aleksandra Czumaj, Jacek Turyn, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14857-14857
Open Access | Times Cited: 16
Use of dicarboxylic acids in type 2 diabetes
Geltrude Mingrone, Lidia Castagneto‐Gissey, Katherine Macé
British Journal of Clinical Pharmacology (2012) Vol. 75, Iss. 3, pp. 671-676
Open Access | Times Cited: 59
Geltrude Mingrone, Lidia Castagneto‐Gissey, Katherine Macé
British Journal of Clinical Pharmacology (2012) Vol. 75, Iss. 3, pp. 671-676
Open Access | Times Cited: 59
Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance
Christoph Nowak, Susanne Hetty, Samira Salihović, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Christoph Nowak, Susanne Hetty, Samira Salihović, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Hepatic CPT1A Facilitates Liver–Adipose Cross Talk via Induction of FGF21 in Mice
Wei Sun, Tao Nie, Kuai Li, et al.
Diabetes (2021) Vol. 71, Iss. 1, pp. 31-42
Open Access | Times Cited: 39
Wei Sun, Tao Nie, Kuai Li, et al.
Diabetes (2021) Vol. 71, Iss. 1, pp. 31-42
Open Access | Times Cited: 39
Modulators for palmitoylation of proteins and small molecules
Zeshuai Fan, Yuchen Hao, Yidan Huo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116408-116408
Closed Access | Times Cited: 5
Zeshuai Fan, Yuchen Hao, Yidan Huo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116408-116408
Closed Access | Times Cited: 5
Mitochondrial fatty acid oxidation as the target for blocking therapy-resistance and inhibiting tumor recurrence: The proof-of-principle model demonstrated for ovarian cancer cells
Hui‐Yi Lin, Lingfang Wang, Hanwen Chen, et al.
Journal of Advanced Research (2025)
Open Access
Hui‐Yi Lin, Lingfang Wang, Hanwen Chen, et al.
Journal of Advanced Research (2025)
Open Access